Kyle M. Miller, PhD

Biography

Kyle M. Miller, PhD, is a professor in the Department of Radiation Oncology at Emory University School of Medicine. Dr. Miller is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University. Prior to joining Emory, he was on faculty and held the Fellow of the Lorene Morrow Kelley Professorship in the Department of Molecular Biosciences at the University of Texas at Austin in Austin, Texas.

Dr. Miller was a former member of the Livestrong Cancer Institutes, Dell Medical School at the University of Texas at Austin and an adjunct member at the Dan L Duncan Cancer Center's Cancer Evolvability Program at Baylor College of Medicine in Houston, Texas.

Education

Dr. Miller received his PhD from the University College London at the London Research Institute in London, United Kingdom. He then completed postdoctoral fellowship at the University of California San Francisco and at the Gurdon Institute, University of Cambridge in England.

Titles & Roles

• Professor, Department of Radiation Oncology

  Emory University School of Medicine

Research

A cellular and molecular geneticist, Dr. Miller's research aims to understand genome integrity mechanisms and the DNA damage response in the context of chromatin, cancer and anticancer therapies. His lab employs genetics, genomics, cell biology and molecular biology in both mouse and human tissue culture systems to gain insights into these areas of research including during DNA repair, replication and telomere maintenance. His lab applies multifaceted and diverse approaches to these areas of research in hopes of defining the relationship between chromatin and genome integrity mechanisms, as well as gaining insights into how cancer therapeutic drugs act at the chromatin and DNA level. His work has obtained funding from the National Cancer Institute, Cancer Prevention Research Institute of Texas, American Cancer Society, the Keck Foundation and NASA.

Publications

Dr. Miller has authored numerous publications in high impact journals, including Nature, Nature Genetics, Genes & Development, Journal of Cell Biology, Cell and Molecular Cell. He serves on the editorial boards of Life Science Alliances and PLoS Genetics.